Search clinical trials for: chemotherapy tolerance

Total 14646 results

The Leeds Teaching Hospitals NHS Trust

Recruiting

Tolerance of Anti-Cancer Therapy in the Elderly (TOASTIE)

Frailty | Chemotherapeutic Toxicity

United Kingdom
National Cancer Institute (NCI)
NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaborators

Active, not recruiting

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) (TAILORx)

Hormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast Adenocarcinoma

United States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma

United States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
University Medical Center Groningen

Completed

Taste, Smell and Chemotherapy (TASTY) (TASTY)

Testicular Cancer

Netherlands
Cairo University
Misr International University

Completed

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Advanced Epithelial Ovarian Cancer

Egypt
Eastern Cooperative Oncology Group

Terminated

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Lymphoma

United States
Harbour BioMed US, Inc.

Completed

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Australia, China, Hong Kong
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer (DEGASTIM)

Invasive Ductal Breast Carcinoma

France
Azienda Ospedaliero-Universitaria Careggi

Completed

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer (ANCHISES)

Metastatic Prostate Cancer | Elderly Patients

Italy
Translational Oncology Research International
Sanofi; University of California, Los Angeles; OSI Pharmaceuticals

Completed

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Unresectable Adenocarcinoma of the Esophagus | Metastatic Adenocarcinoma of the Esophagus | Unresectable Adenocarcinoma of Gastric Cardia | Metastatic Adenocarcinoma of Gastric Cardia

United States
UNICANCER

Completed

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Massachusetts General Hospital
National Cancer Institute (NCI)

Unknown

Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients

Colonic Neoplasms

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Terminated

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States
Royal Marsden NHS Foundation Trust

Unknown

Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer (FAIR-O)

Quality of Life | Ovarian Cancer | Chemotherapy | Tolerance | Aged
UNICANCER

Terminated

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Colorectal Cancer

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Sprint for Life

Completed

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditions

United States
Hospices Civils de Lyon

Unknown

Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma (ICONIC)

Ovarian Cancer

France
Augusta University
University of Georgia

Completed

Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens (FOND-O)

Hematologic Neoplasms | Complications of Bone Marrow Transplant

United States
Centre Henri Becquerel

Unknown

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)

Early Stage Breast Carcinoma

France
Peking University

Unknown

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Gastric Cancer

China
Faculdade de Medicina do ABC

Unknown

The Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease. (TK3bFIIABC)

Quality of Life | Cancer | Chemotherapy Effect | Tryptophan | Thiamine

Brazil
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy (TAPIS)

HNSCC

France
Indiana University

Completed

Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy

Chemotherapy Induced Nausea and Vomiting

United States
University of Miami

Withdrawn

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

Lymphoma

United States
Radboud University Medical Center

Unknown

Intra-peritoneal Chemotherapy in Ovarian Cancer

Neoplasms | Ovarian Neoplasms | Effects of Chemotherapy | Immune Tolerance

Netherlands
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Withdrawn

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Colorectal Cancer
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

Colorectal Cancer

United States, Puerto Rico, Canada
Leiden University Medical Center

Completed

Effects of Short-term Fasting on Tolerance to Chemotherapy

Breast Cancer

Netherlands
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Solid Tumors | Malignant Hemopathy | Chemotherapy-induced Febrile Neutropenia (FN)

France
University of Southern California
Novartis

Terminated

Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Leukemia | Thrombocytopenia | Neutropenia

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients (EBS)

Breast Cancer | Elderly

Belgium
National Cancer Institute (NCI)

Completed

Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Adult Acute Lymphoblastic Leukemia in Remission

United States
Memorial Sloan Kettering Cancer Center

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer

Colorectal Cancer

United States
Johann Wolfgang Goethe University Hospital

Unknown

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

Leukemia

Germany
Southern Italy Cooperative Oncology Group

Unknown

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Italy
Hannover Medical School

Unknown

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Leukemia

Germany
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States, Puerto Rico, South Africa
Hospital Clinic of Barcelona
Abbott

Terminated

Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients

Colorectal Neoplasms

Spain
University of Tennessee
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Oral Collagen for Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Stanford University
National Cancer Institute (NCI)

Completed

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Colorectal Cancer

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

Colorectal Cancer

United States, Canada
National Cancer Institute, France
University Hospital, Grenoble

Completed

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung (ERBIFORT)

Colorectal Cancer | Metastatic Cancer

France
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Phase II 5-Azacytidine Plus VPA Plus ATRA

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Colorectal Cancer | Metastatic Cancer

United States
Institut Cancerologie de l'Ouest

Completed

Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

France
Centre Hospitalier Universitaire Vaudois

Unknown

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Colorectal Cancer | Metastatic Cancer

Switzerland
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Unknown

Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx

Head and Neck Cancer

United States
Association Pour La Recherche des Thérapeutiques...

Unknown

Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen

Breast Neoplasms | Chemotherapy

France
Fudan University

Not yet recruiting

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer | Gastro Esophageal Junction Cancer

China

Search clinical trials for: chemotherapy tolerance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations